Closure of patent foramen ovale: When and how?

Veronica Lisignoli, Alberto M. Lanzone, Dennis Zavalloni, Paolo Pagnotta, Patrizia Presbitero

Research output: Contribution to journalArticle

Abstract

Percutaneous closure of a patent foramen ovale (PFO) was performed in 98 consecutive patients (mean age 52.5 ± 13 years, 61 women), Indications included recurrent transient ischaemic attack (47%), cryptogenic stroke (34%), peripheral embolism (11%), disabling migraine with aura (4%), professional scuba diving (1 pt) and severe platypnea-orthodeoxia syndrome (1 pt). Each PFO was characterized by transesophageal echocardiography (TEE) according to anatomy, degree of shunt (1-mild, 2-moderate, 3-severe), right atrial anatomical features relevant for PFO closure (such as presence of an Eustachian valve, Chiari network, lipomatosis or absence of septum secundum) with a new classification scheme. According to this classification successful device delivery was obtained in 100% of pts. Major complications included heparin-induced thrombocytopenia in 1 pt and device dislodgment in 1 pt; minor complications were mostly related to the catheter introduction site (2 pts) and mild immediate shunt (2 pts). In conclusion, percutaneous PFO closure based on strict anatomic criteria is a safe procedure with minimal periprocedural complications.

Original languageEnglish
Pages (from-to)322-327
Number of pages6
JournalCurrent Vascular Pharmacology
Volume5
Issue number4
DOIs
Publication statusPublished - Oct 2007

Fingerprint

Patent Foramen Ovale
Lipomatosis
Migraine with Aura
Equipment and Supplies
Diving
Transient Ischemic Attack
Transesophageal Echocardiography
Embolism
Heparin
Anatomy
Catheters
Stroke

Keywords

  • Anatomical classification
  • Cryptogenic stroke
  • Patent foramen ovale
  • Transesophageal echocardiography

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pharmacology

Cite this

Closure of patent foramen ovale : When and how? / Lisignoli, Veronica; Lanzone, Alberto M.; Zavalloni, Dennis; Pagnotta, Paolo; Presbitero, Patrizia.

In: Current Vascular Pharmacology, Vol. 5, No. 4, 10.2007, p. 322-327.

Research output: Contribution to journalArticle

Lisignoli, Veronica ; Lanzone, Alberto M. ; Zavalloni, Dennis ; Pagnotta, Paolo ; Presbitero, Patrizia. / Closure of patent foramen ovale : When and how?. In: Current Vascular Pharmacology. 2007 ; Vol. 5, No. 4. pp. 322-327.
@article{88b007171a454f9997ce9f646c19ae90,
title = "Closure of patent foramen ovale: When and how?",
abstract = "Percutaneous closure of a patent foramen ovale (PFO) was performed in 98 consecutive patients (mean age 52.5 ± 13 years, 61 women), Indications included recurrent transient ischaemic attack (47{\%}), cryptogenic stroke (34{\%}), peripheral embolism (11{\%}), disabling migraine with aura (4{\%}), professional scuba diving (1 pt) and severe platypnea-orthodeoxia syndrome (1 pt). Each PFO was characterized by transesophageal echocardiography (TEE) according to anatomy, degree of shunt (1-mild, 2-moderate, 3-severe), right atrial anatomical features relevant for PFO closure (such as presence of an Eustachian valve, Chiari network, lipomatosis or absence of septum secundum) with a new classification scheme. According to this classification successful device delivery was obtained in 100{\%} of pts. Major complications included heparin-induced thrombocytopenia in 1 pt and device dislodgment in 1 pt; minor complications were mostly related to the catheter introduction site (2 pts) and mild immediate shunt (2 pts). In conclusion, percutaneous PFO closure based on strict anatomic criteria is a safe procedure with minimal periprocedural complications.",
keywords = "Anatomical classification, Cryptogenic stroke, Patent foramen ovale, Transesophageal echocardiography",
author = "Veronica Lisignoli and Lanzone, {Alberto M.} and Dennis Zavalloni and Paolo Pagnotta and Patrizia Presbitero",
year = "2007",
month = "10",
doi = "10.2174/157016107782023370",
language = "English",
volume = "5",
pages = "322--327",
journal = "Current Vascular Pharmacology",
issn = "1570-1611",
publisher = "Bentham Science Publishers B.V.",
number = "4",

}

TY - JOUR

T1 - Closure of patent foramen ovale

T2 - When and how?

AU - Lisignoli, Veronica

AU - Lanzone, Alberto M.

AU - Zavalloni, Dennis

AU - Pagnotta, Paolo

AU - Presbitero, Patrizia

PY - 2007/10

Y1 - 2007/10

N2 - Percutaneous closure of a patent foramen ovale (PFO) was performed in 98 consecutive patients (mean age 52.5 ± 13 years, 61 women), Indications included recurrent transient ischaemic attack (47%), cryptogenic stroke (34%), peripheral embolism (11%), disabling migraine with aura (4%), professional scuba diving (1 pt) and severe platypnea-orthodeoxia syndrome (1 pt). Each PFO was characterized by transesophageal echocardiography (TEE) according to anatomy, degree of shunt (1-mild, 2-moderate, 3-severe), right atrial anatomical features relevant for PFO closure (such as presence of an Eustachian valve, Chiari network, lipomatosis or absence of septum secundum) with a new classification scheme. According to this classification successful device delivery was obtained in 100% of pts. Major complications included heparin-induced thrombocytopenia in 1 pt and device dislodgment in 1 pt; minor complications were mostly related to the catheter introduction site (2 pts) and mild immediate shunt (2 pts). In conclusion, percutaneous PFO closure based on strict anatomic criteria is a safe procedure with minimal periprocedural complications.

AB - Percutaneous closure of a patent foramen ovale (PFO) was performed in 98 consecutive patients (mean age 52.5 ± 13 years, 61 women), Indications included recurrent transient ischaemic attack (47%), cryptogenic stroke (34%), peripheral embolism (11%), disabling migraine with aura (4%), professional scuba diving (1 pt) and severe platypnea-orthodeoxia syndrome (1 pt). Each PFO was characterized by transesophageal echocardiography (TEE) according to anatomy, degree of shunt (1-mild, 2-moderate, 3-severe), right atrial anatomical features relevant for PFO closure (such as presence of an Eustachian valve, Chiari network, lipomatosis or absence of septum secundum) with a new classification scheme. According to this classification successful device delivery was obtained in 100% of pts. Major complications included heparin-induced thrombocytopenia in 1 pt and device dislodgment in 1 pt; minor complications were mostly related to the catheter introduction site (2 pts) and mild immediate shunt (2 pts). In conclusion, percutaneous PFO closure based on strict anatomic criteria is a safe procedure with minimal periprocedural complications.

KW - Anatomical classification

KW - Cryptogenic stroke

KW - Patent foramen ovale

KW - Transesophageal echocardiography

UR - http://www.scopus.com/inward/record.url?scp=38449093244&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38449093244&partnerID=8YFLogxK

U2 - 10.2174/157016107782023370

DO - 10.2174/157016107782023370

M3 - Article

C2 - 17979798

AN - SCOPUS:38449093244

VL - 5

SP - 322

EP - 327

JO - Current Vascular Pharmacology

JF - Current Vascular Pharmacology

SN - 1570-1611

IS - 4

ER -